Rapid sodium correction (>10 mEq/L/24 h) in cancer patients with severe hyponatremia was independently associated with lower in-hospital mortality (adjusted OR 0.58) compared to slower rates.
Does rapid sodium correction (>10 mEq/L/24 h) reduce mortality compared to slow correction (<6 mEq/L/24 h) in adult cancer patients with severe hyponatremia?
In hospitalized cancer patients with severe hyponatremia, rapid sodium correction (>10 mEq/L/24 h) is associated with improved survival without significant neurological complications compared to slow correction.
Absolute Event Rate: 0% vs 0%
Background: Hyponatremia is a common electrolyte disturbance among hospitalized cancer patients and is associated with increased morbidity and mortality. Optimal correction rates for severe hyponatremia remain debated, particularly in oncology populations where comorbidities and treatment-related factors complicate management. Methods: We conducted a retrospective cohort study of adult cancer patients admitted to Shaukat Khanum Memorial Cancer Hospital p = 0.003; 30-day: 55.3% vs 20.6%; p 10 mEq/L/24 h was independently associated with lower in-hospital mortality (adjusted OR = 0.58; 95% CI: 0.36–0.92; p = 0.021). One case of osmotic demyelination was identified. Conclusions: In hospitalized cancer patients with severe hyponatremia, slow correction (10 mEq/L/24 h) was linked to improved survival without significant neurological complications. Prospective multicenter studies are warranted to investigate the associations between the different etiologies of hyponatremia and mortality.
Khan et al. (Wed,) reported a other. Rapid sodium correction (>10 mEq/L/24 h) in cancer patients with severe hyponatremia was independently associated with lower in-hospital mortality (adjusted OR 0.58) compared to slower rates.